Misplaced Pages

Deep transcranial magnetic stimulation

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.

This is an old revision of this page, as edited by SandyGeorgia (talk | contribs) at 00:31, 21 November 2013 (WP:CITEVAR, message left on new editor talk). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Revision as of 00:31, 21 November 2013 by SandyGeorgia (talk | contribs) (WP:CITEVAR, message left on new editor talk)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Medical intervention
Deep transcranial magnetic stimulation
File:H-coil helmet.jpgH-coil helmet for deep transcranial magnetic stimulation (schematic diagram)
[edit on Wikidata]

Deep transcranial magnetic stimulation (Deep TMS) is a non-invasive technique for excitation of large populations of neurons in the brain.

Use

Deep TMS uses the basic principles of transcranial magnetic stimulation (TMS) but expands them from the use of a single focal stimulation source to a summation of several simultaneous operating elements. The brain regions affected directly by this technique are determined by the shape of the TMS coil. Standard TMS coils induce direct stimulation of superficial brain areas, while Deep TMS coils (H-coils) induce summation of fields, allowing deeper penetration of the brain. To affect different areas of the brain (depending on the targeted disorder), specific versions of H-coils are installed within a helmet placed on the subject's head.

Deep TMS coils have been studied in healthy humans and people with major depressive disorder, autism, bipolar disorder, auditory hallucinations, and schizophrenia.

History

The technology was developed by Abraham Zangen and Yiftach Roth starting in 2001 and a patent was filed by the United States National Institutes of Health. In January 2013, the United States Food and Drug Administration permitted a manufacturer to market a Deep TMS device that was indicated for the treatment of depressive episodes in adult patients suffering from major depressive disorder who failed to achieve satisfactory improvement from previous anti-depressant medication treatment in the current episode.

References

  1. Bersani FS, Minichino A, Enticott PG; et al. (2013). "Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: a comprehensive review". Eur. Psychiatry. 28 (1): 30–9. doi:10.1016/j.eurpsy.2012.02.006. PMID 22559998. {{cite journal}}: Explicit use of et al. in: |author= (help); Unknown parameter |month= ignored (help)CS1 maint: multiple names: authors list (link)
  2. Krauthamer, Victor (2013-01-07). "Letter to Brainsway, Ltd" (PDF). 510(k)Summary for K12288: Brainsway Deep TMS System. Silver Spring, MD: Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration. Retrieved 2013-11-20.
Categories: